Learn More
Invitrogen™ GIT2 Polyclonal Antibody

Description
Recommended positive controls: 293T, A431, HeLa, HepG2, mouse liver. Predicted reactivity: Mouse (96%), Rat (97%), Xenopus laevis (93%), Chicken (96%), Rhesus Monkey (99%), Bovine (99%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Specifications
Specifications
| Antigen | GIT2 |
| Applications | Immunohistochemistry (Frozen), Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 0.81 mg/mL |
| Conjugate | Unconjugated |
| Formulation | 0.1M tris glycine with 20% glycerol and 0.01% thimerosal; pH 7 |
| Gene | GIT2 |
| Gene Accession No. | Q14161, Q9JLQ2 |
| Gene Alias | 1500036H07Rik; 5830420E16Rik; 6430510B20Rik; 9630056M03Rik; ARF GAP GIT2; ARF GTPase activating protein 2; ARF GTPase-activating protein GIT2; B230104M05Rik; CAT2; CAT-2; cool associated tyrosine phosphorylated-2; cool-associated, tyrosine phosphorylated protein 2; cool-interacting tyrosine-phosphorylated protein 2; G protein-coupled receptor kinase interacting ArfGAP 2; G protein-coupled receptor kinase-interactor 2; GIT ArfGAP 2; Git2; GRK-interacting protein 2; KIAA0148; mKIAA0148; Paxillin kinase linker; PKL |
| Gene Symbols | GIT2 |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.